Statutory Instruments Act (R.S.C., 1985, c. S-22)

RELATED PROVISIONS

• — 2012, c. 19, s. 417

  • Interim marketing authorization

    • 417 (1) An interim marketing authorization that is issued under subsection 30.2(1) of the Food and Drugs Act and in effect immediately before the day on which section 416 comes into force continues to have effect until the earliest of

      • (a) the day on which the Minister of Health publishes a notice cancelling the interim marketing authorization in the Canada Gazette;

      • (b) the day on which a marketing authorization — or any part of it — that is issued under subsection 30.3(1) of the Food and Drugs Act, as enacted by section 416, has the same effect as the interim marketing authorization; and

      • (c) two years after the day on which the interim marketing authorization is published in the Canada Gazette.

    • Exemption from Statutory Instruments Act

      (2) A notice cancelling an interim marketing authorization is exempt from sections 3, 5 and 11 of the Statutory Instruments Act.

• — 2012, c. 31, s. 96

  • 96 The Input Tax Credit Allocation Methods (GST/HST) Regulations are deemed

    • (a) to have been made under section 277 of the Excise Tax Act;

    • (b) for the purposes of subsection 5(1) of the Statutory Instruments Act, to have been transmitted to the Clerk of the Privy Council for registration; and

    • (c) to have met the publication requirements of subsection 11(1) of the Statutory Instruments Act.